APA (7th ed.) Citation

Djeddi, D., Hogan, J., Perez, A., Sellier-Leclerc, A., Vrillon, I., Broux, F., . . . Deschênes, G. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: Protocol for a multicentre randomised controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Djeddi, Djamal, et al. Efficacy and Safety of Intravenous Immunoglobulin with Rituximab Versus Rituximab Alone in Childhood-onset Steroid-dependent and Frequently Relapsing Nephrotic Syndrome: Protocol for a Multicentre Randomised Controlled Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Djeddi, Djamal, et al. Efficacy and Safety of Intravenous Immunoglobulin with Rituximab Versus Rituximab Alone in Childhood-onset Steroid-dependent and Frequently Relapsing Nephrotic Syndrome: Protocol for a Multicentre Randomised Controlled Trial. BMJ Publishing Group.